SNSE SCHEDULE 13G/A: SEC filing

Montanova Capital, LLC and related reporting persons

Filed with the SEC on Nov 13, 2026 · accession 0000919574-26-007764

SNSE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. Montanova Capital, LLC and related reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 8.9% of Faeth Therapeutics' common stock as of September 30, 2026.

Summary of the filing

Montanova Capital, LLC and related reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 8.9% of Faeth Therapeutics' common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

For details, click here →

Key details

Shares beneficially owned by Montanova Capital, LLC$2.3M

Shares beneficially owned by Averill Master Fund, Ltd.$2.0M

Reporting person / investment adviserMontanova Capital, LLC

Reporting person / advisory clientAverill Master Fund, Ltd.

IssuerFaeth Therapeutics, Inc.

Control person of montanova capital, llcAaron Cowen

General counsel and chief compliance officer, montanova capital, llcAndrew Nathanson

✦ Ask GOAX AI about this filing — what it means for SNSE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SNSE?

Click here

Frequently asked questions

What did SNSE file with the SEC on Nov 13, 2026?

SNSE filed a SCHEDULE 13G/A (SEC filing). Montanova Capital, LLC and related reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 8.9% of Faeth Therapeutics' common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other SNSE SEC filings

Get alerts when SNSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SNSE overview SNSE analysis SNSE news Latest SEC filings